title: [Significance of pharmacological blockade of angiotensin II type I receptors for correction of abnormal 24-hour blood pressure profile depending on its variability in patients with arterial hypertension stage II].
abstract: OBJECTIVE
  To specify variable 24-h arterial hypertension (AH) stage II profile and to assess significance of pharmacological block of the end of the renin-angiotensin-aldosteron system for correction of the determined disorders.
  
  
  METHODS
  The study was made of 46 men (mean age 42.8 +/- 3.28 years) with stage II AH and 25 normotensive controls (mean age 39.2 +/- 3.10 years). Depending on the magnitude of mean 24-h AP variability (APV), hypertensive patients were divided into two groups. Variability of systolic and/or diastolic AP (SAPV and DAPV, respectively) was considered high in at least 15.2 and/or 12.3 mm Hg variability, respectively, and normal at less values.
  
  
  RESULTS
  AP 24-h profile in men with AH stage II and high APV compared to patients with normal APV is characterized by higher frequency of AP rise and less frequency of its night fall. In patients with high APV the drug eprosartan (teveten) is more effective in correction of hypertension and night fall of AP.
  
  
  CONCLUSIONS
  Eprosartan has an adequate corrective activity in relation to absolute values of SAP and DAP in different hours. The highest hypotensive activity of the drug was seen in persons with initially high circadian AP variability within 24 hours.
authors.forename: S B
authors.initials: SB
authors.lastname: Shustov
authors.forename: A V
authors.initials: AV
authors.lastname: Barsukov
authors.forename: M A
authors.initials: MA
authors.lastname: Al'-Iazidi
authors.forename: A N
authors.initials: AN
authors.lastname: Kulikov
authors.forename: A V
authors.initials: AV
authors.lastname: Konev
mesh_terms: D000179:Acrylates / Q000627:therapeutic use; D000328:Adult; D000804:Angiotensin II / Q000378:metabolism*; D057911:Angiotensin Receptor Antagonists; D001794:Blood Pressure / Q000187:drug effects*; D002940:Circadian Rhythm; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D044140:Receptor, Angiotensin, Type 1; D013876:Thiophenes
chemical_list: D000179:Acrylates; D057911:Angiotensin Receptor Antagonists; D007093:Imidazoles; D044140:Receptor, Angiotensin, Type 1; D013876:Thiophenes; D000804:Angiotensin II; C068373:eprosartan